Hinge Health, Inc. is trading 5% up today at $65.17 after the company raised its 2026 revenue guidance ahead of its first Investor Day, significantly boosting investor confidence in its long-term growth outlook.
- The upward revision in revenue targets precedes the company's inaugural Investor Day, signaling a robust expansion trajectory and improved financial visibility.
- Institutional support remains strong as Needham reiterated a Buy rating and raised its price target to $76, citing positive momentum following the guidance update.